about
An updated review of Zika virusEvidence for association between hepatitis C virus and Parkinson's disease.Parkinson's disease and pesticides: A meta-analysis of disease connection and genetic alterations.Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumor necrosis factor inhibitors: a systematic review and meta-analysis.Neuroprotective mechanisms of plant extracts against MPTP induced neurotoxicity: Future applications in Parkinson's disease.Meta-analysis of Creatine for neuroprotection against Parkinson's disease.Efficacy and safety of atazanavir/ritonavir-based antiretroviral therapy for HIV-1 infected subjects: a systematic review and meta-analysis.Self-gripping versus sutured mesh fixation methods for open inguinal hernia repair: A systematic review of clinical trials and observational studies.Safety and efficacy of sofosbuvir plus ledipasvir with and without ribavirin for chronic HCV genotype-1 infection: a systematic review and meta-analysis.Safety and Efficacy of Brodalumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis.Dexamethasone combined with other antiemetics versus single antiemetics for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: An updated systematic review and meta-analysis.Caffeine; the forgotten potential for Parkinson's disease.Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin for Treatment of Hepatitis C Virus Genotype 1: A Systematic Review and Meta-analysis.Safety and efficacy of sofosbuvir plus velpatasvir with or without ribavirin for chronic hepatitis C virus infection: A systematic review and meta-analysis.Meta-Analysis of Grazoprevir plus Elbasvir for Treatment of Hepatitis C Virus Genotype 1 Infection.Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis.Meta-analysis of safety and efficacy of rolapitant, NK-1 receptor antagonist for prevention of chemotherapy-induced nausea and vomiting.Efficacy of daclatasvir plus peginterferon alfa and ribavirin for patients with chronic hepatitis C genotype 4 infectionReal-World Safety and Effectiveness Of Retreatment Of Egyptian Chronic Hepatitis C Patients Not Responding to NS5A Inhibitor-Based Therapies
P50
Q27087932-3EAE1E4C-0FE2-42C8-BE01-367082FFD937Q38638550-78C4BF43-B99A-48D5-AFD9-D45426538817Q38729967-63C06398-3829-4F52-B2A8-A99921EF6E8CQ38753455-4727C185-E38E-428E-82C0-3D45ECDDB64FQ38790303-943CB696-DC76-40CA-BADB-D37055040FD5Q38797591-EFC6D7F3-6249-48CA-87D4-992B923E152FQ38865547-CCAA432A-2C5B-4AC8-8F32-E5368740F40FQ38935210-7847874E-0886-4BC8-B51F-2F8387FA1D92Q38944807-BF870127-8E72-4AF0-B8FF-C53837D2F524Q38961129-2DB25E70-4E71-4EB5-B9C6-20EADF238DBCQ38994076-15F07516-B904-4F6C-8BDA-EC35AF232E7DQ39002427-2AA01FF7-CE14-4029-BFF5-E49A1981F59FQ40058097-EC077E18-9DB9-4B07-BE88-D5D568A7A531Q41926040-9FFDDA0C-CDC4-4AF1-928A-3CCF2CB7372FQ47557071-680DD133-1A5B-4C5F-943D-D1913D0E580FQ47932320-100BEE9B-BFEA-474B-9262-79A7B57B2D71Q50134995-D363CA6A-2C9F-433A-B98A-3F0861059E35Q56768099-1BAB2488-D08C-41B6-87C9-FE0D9DF4272AQ96618184-D714BC54-D1A2-48D0-B530-0ADD4E583BF5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Hussien Ahmed
@ast
Hussien Ahmed
@en
Hussien Ahmed
@es
Hussien Ahmed
@nl
Hussien Ahmed
@sl
type
label
Hussien Ahmed
@ast
Hussien Ahmed
@en
Hussien Ahmed
@es
Hussien Ahmed
@nl
Hussien Ahmed
@sl
altLabel
Clinical Researcher
@en
MD candidate
@en
prefLabel
Hussien Ahmed
@ast
Hussien Ahmed
@en
Hussien Ahmed
@es
Hussien Ahmed
@nl
Hussien Ahmed
@sl
P214
P2163
P244
P106
P1153
57191482342
P21
P214
P2163
P244
P31
P496
0000-0001-7101-837X
P734
P7859
lccn-n97842740